ATE197609T1 - Verfahren zur unterdrückung der immunantwort durch gentherapie - Google Patents
Verfahren zur unterdrückung der immunantwort durch gentherapieInfo
- Publication number
- ATE197609T1 ATE197609T1 AT94929135T AT94929135T ATE197609T1 AT E197609 T1 ATE197609 T1 AT E197609T1 AT 94929135 T AT94929135 T AT 94929135T AT 94929135 T AT94929135 T AT 94929135T AT E197609 T1 ATE197609 T1 AT E197609T1
- Authority
- AT
- Austria
- Prior art keywords
- suppressing
- immune response
- antigen presentation
- mhc antigen
- gene therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/122—Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11682893A | 1993-09-03 | 1993-09-03 | |
PCT/US1994/009958 WO1995006744A2 (en) | 1993-09-03 | 1994-09-02 | Methods of suppressing immune response by gene therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE197609T1 true ATE197609T1 (de) | 2000-12-15 |
Family
ID=22369476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94929135T ATE197609T1 (de) | 1993-09-03 | 1994-09-02 | Verfahren zur unterdrückung der immunantwort durch gentherapie |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0716710B1 (de) |
JP (1) | JPH09504168A (de) |
AT (1) | ATE197609T1 (de) |
AU (1) | AU7830794A (de) |
CA (1) | CA2158934A1 (de) |
DE (1) | DE69426303T2 (de) |
WO (1) | WO1995006744A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5624803A (en) * | 1993-10-14 | 1997-04-29 | The Regents Of The University Of California | In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom |
CA2186528A1 (en) * | 1994-03-31 | 1995-10-12 | E. Michael Egan | Genetically modified cells for use in transplantation |
US6506379B1 (en) | 1995-06-07 | 2003-01-14 | Ariad Gene Therapeutics, Inc. | Intramuscular delivery of recombinant AAV |
CA2230195A1 (en) * | 1995-08-21 | 1997-02-27 | Duke University | A method to increase the density of antigen on antigen presenting cells |
US6692910B2 (en) | 1997-07-28 | 2004-02-17 | The University Of Connecticut | Inhibition of a target messenger RNA with a modified U1 small nuclear RNA |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993005817A1 (en) * | 1991-09-19 | 1993-04-01 | President And Fellows Of Harvard College | Transgenic mhc class i and class ii antigen-deficient mammals |
CA2121370C (en) * | 1991-11-22 | 2003-03-18 | David H. Sachs | Specific tolerance in transplantation |
CA2126692A1 (en) * | 1992-01-31 | 1993-08-05 | Tania L. Weiss | Method for making universal donor cells |
WO1994016065A1 (en) * | 1992-12-31 | 1994-07-21 | Exemplar Corporation | Producing cells for transplantation to reduce host rejection and resulting cells |
-
1994
- 1994-09-02 CA CA002158934A patent/CA2158934A1/en not_active Abandoned
- 1994-09-02 EP EP94929135A patent/EP0716710B1/de not_active Expired - Lifetime
- 1994-09-02 WO PCT/US1994/009958 patent/WO1995006744A2/en active IP Right Grant
- 1994-09-02 AU AU78307/94A patent/AU7830794A/en not_active Abandoned
- 1994-09-02 AT AT94929135T patent/ATE197609T1/de not_active IP Right Cessation
- 1994-09-02 JP JP7508295A patent/JPH09504168A/ja active Pending
- 1994-09-02 DE DE69426303T patent/DE69426303T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH09504168A (ja) | 1997-04-28 |
EP0716710B1 (de) | 2000-11-15 |
WO1995006744A3 (en) | 1995-04-06 |
EP0716710A1 (de) | 1996-06-19 |
DE69426303T2 (de) | 2001-05-31 |
WO1995006744A2 (en) | 1995-03-09 |
AU7830794A (en) | 1995-03-22 |
CA2158934A1 (en) | 1995-03-09 |
DE69426303D1 (de) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Miyahira et al. | Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice | |
DE69114299D1 (de) | Verfahren und zusammensetzungen für gentherapie und stärkung des immunsystems. | |
DK0870022T3 (da) | Immunstimulerende sammensætning og fremgangsmåde | |
DE69518910D1 (de) | Verfahren zur herstellung von viralen vektoren von mindestens 20kb durch intermolekulare homologe rekombination in einer prokaryotischen zelle | |
ATE411043T1 (de) | Verfahren von dna-impfung | |
EP1135149A4 (de) | Pcg-1, ein neuer koaktivator für den ppar gamma rezeptor im braunen fettgewebe | |
NO960309L (no) | Agonister og antagonister for humaninterleukin-10 | |
DK1222298T3 (da) | Vektorer og fremgangsmåder til rekombinant proteinekspression | |
ATE352561T1 (de) | Pgc-1, ein neuartiger ppar-gamma-koaktivator aus braunem fettgewebe | |
WO2023094713A3 (en) | Coronavirus vaccine | |
WO2023147092A3 (en) | Coronavirus vaccine | |
ATE197609T1 (de) | Verfahren zur unterdrückung der immunantwort durch gentherapie | |
WO2001087978A3 (en) | Human abc transporter and its use | |
Delman et al. | Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer | |
MXPA04004561A (es) | Distribuidor de aire para sistema de biolixiviacion. | |
AU2002211446A1 (en) | 32144, a human fatty acid amide hydrolase and uses thereof | |
WO1995006718A3 (en) | Methods of suppressing autoimmune response | |
WO2001075121A3 (en) | 16836, a human phospholipase c family member and uses thereof | |
WO1995006717A3 (en) | Methods of suppressing graft rejection | |
WO2001075076A3 (en) | 33167, a novel human hydrolase and uses therefor | |
WO2001014414A3 (en) | Human abc2 transporter and uses thereof | |
ATE445714T1 (de) | 15603, ein mitglied der humanen ionenkanal- familie | |
ATE346926T1 (de) | Menschliche twik-8 moleküle und ihre verwendung | |
WO2002088357A3 (en) | 84242, 8035, 55304, 52999, and 21999, novel human proteins and methods of use thereof | |
EP1225182A3 (de) | Humaner Phospholipidtransporter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |